Identification of (CAG)(n) and (CGG)(n) repeat-binding proteins, CAGERs expressed in mature neurons of the mouse brain

Experimental Cell Research

Volumn 251, Issue 2, 1999, Pages 388-400

  Yano, Hiroko ^a   Wang, Bu Er ^a   Ahmad, Ishtiyaque ^a   Zhang, Jianzhong ^a   Abo, Tatsuhiko ^a   Nakayama, Jun ^a   Krempen, Kimberly ^a   Kohwi, Yoshinori ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

(CAG) and (CGG) repeats; CAGERs; Neurons; Pur ; Triplet repeat diseases

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; NUCLEOTIDE BINDING PROTEIN; PROTEIN CAGER 1; PROTEIN CAGER 2; RNA BINDING PROTEIN; TRINUCLEOTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN COS1; CONTROLLED STUDY; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOLECULAR WEIGHT; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRINUCLEOTIDE REPEAT;

ANIMALIA;

EID: 0033568031     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4603     Document Type: Article

References (28)

1. Paulson H. L., Fishbeck K. H. Trinucleotide repeats in neurogenic disorders. Annu. Rev. Neurosci. 19:1996;79-107.
2. Timchenko L. T., Caskey C. T. Trinucleotide repeat disorders in human: Discussions of mechanism and medical issues. FASEB J. 10:1996;1589-1597.
3. Warren S. T. The expanding world of trinucleotide repeats. Science. 271:1996;1374-1375.
4. Gordenin D. A., Kunkel T. A., Resnick M. A. Repeat expansion - All in a flap. Nature Genet. 16:1997;116-118.
5. Mitas M. Trinucleotide repeats associated with human disease. Nucleic Acids Res. 25:1997;2245-2253.
6. Dijan P. Evolution of simple repeats in DNA and their relation to human disease. Cell. 94:1998;155-160.
7. Samadashwily G. M., Raca G., Mirkin S. M. Trinucleotide repeats affect DNA replication in vivo. Nature Genet. 17:1997;298-304.
8. Kohwi Y., Wang H., Kohwi-Shigematsu T. A single trinucleotide, 5′AGC3′/5′GCT3′, of the triplet-repeat disease genes confers metal ion-induced non-B DNA structure. Nucleic Acids Res. 21:1993;5651-5655.
9. Yano-Yanagisawa H., Li Y., Wang H., Kohwi Y. Single-stranded DNA binding proteins isolated from mouse brain recognize specific trinucleotide repeat sequences in vitro. Nucleic Acids Res. 23:1995;2654-2660.
10. Lee S. Y., Lee S. Y., Choi Y. TRAF-interacting protein (TRIP): A novel component of the tumor necrosis factor (TNFR)- and CD30-TRAF signaling complexes that inhibit TRAF2-mediated NF-kappaB activation. J. Exp. Med. 185:1997;1275-1285.
11. Lee J. W., Ryan F., Swaffield J. C., Johnston S. A., Moore D. D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature. 374:1995;91-94.
12. Chen R. H., Miettinen P. J., Maruoka E. M., Choy L., Derynck R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature. 377:1995;548-552.
13. Bergemann A. D., Ma Z.-W., Johnson E. M. Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein. Mol. Cell. Biol. 12:1992;5673-5682.
14. Bergemann A. D., Johnson E. M. The HeLa Pur factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication. Mol. Cell. Biol. 12:1992;1257-1265.
15. Ma Z.-W., Bergemann A. D., Johnson E. M. Conservation in human and mouse Purα of a motif common to several proteins involved in initiation of DNA replication. Gene. 149:1994;311-314.
16. Herault Y., Chatelain G., Brun G., Michel D. RNA-dependent DNA binding activity of the Pur factor, potentially involved in DNA replication and gene transcription. Gene Expression. 4:1995;85-93.
17. Kelm R. J. Jr., Elder P. K., Strauch A. R., Getz M. J. Sequence of cDNAs encoding components of vascular actin single-stranded DNA-binding factor 2 establish identity to Purα and Purβ J. Biol. Chem. 272:1997;26727-26733.
18. Lim D. A., Fishell G. J., Alvarez-Buylla A. Postnatal mouse subventricular zone neuronal precursors can migrate and differentiate within multiple levels of the developing neuraxis. Proc. Natl. Acad. Sci. USA. 94:1997;14832-14836.
19. Elis L., Clauser E., Morgan D. O., Edery M., Roth R., Rutter W. J. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell. 45:1986;721-732.
20. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1994;Wiley, New York.
21. Haas S., Thakikunta P., Steplewski A., Johnson E. M., Khalili K., Amini S. A 39-kD DNA-binding protein from mouse brain stimulates transcription of myelin basic protein gene in oligodendrocytic cells. J. Cell Biol. 130:1995;1171-1179.
22. Du Q., Tomkinson A. E., Gardner P. D. Transcriptional regulation of neuronal nicotinic acetylcholine receptor genes. J. Biol. Chem. 272:1997;14990-14995.
23. Jurk M., Weissinger F., Lottspeich F., Schwarz U., Winnacker E.-L. Characterization of the single-strand-specific BPV-1 origin binding protein, SPSF1, as the HeLa Pura factor. Nucleic Acids Res. 24:1996;2799-2806.
24. Milner R. J., Sutcliffe J. G. Gene expression in rat brain. Nucleic Acids Res. 11:1983;5497-5520.
25. Johnson E. M., Chen P.-L., Krachmarov C. P., Barr S. M., Kanovsky M., Ma Z.-W., Lee W.-H. Association of human Purα with the retinoblastoma protein, Rb, regulates binding to the single-stranded DNA Purα recognition element. J. Biol.Chem. 270:1995;24352-24360.
26. Conner J. M., Lauterborn J. C., Yan Q., Gall C. M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport. J. Neurosci. 17:1997;2295-2313.
27. Timchenko L. T., Timchenko N. A., Caskey C. T., Roberts R. Novel proteins with binding activity for DNA CTG and RNA CUG repeats: Implications for myotonic dystrophy. Human Mol. Genet. 5:1996;115-121.
28. Ross C. A. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases. Neuron. 19:1997;1147-1150.